Search Results

AEE788 50 mg  | Purity Not Available

TargetMol

AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.

More Information Supplier Page

AEE788 25 mg  | Purity Not Available

TargetMol

AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.

More Information Supplier Page

AEE788 10 mg  | Purity Not Available

TargetMol

AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.

More Information Supplier Page

Bikinin 25 mg  | 99.91%

TargetMol

Bikinin, a potent inhibitor of plant GSK-3/Shaggy-like kinase, activates BR signaling downstream of the BR receptor.

More Information Supplier Page

Bikinin 50 mg  | 99.91%

TargetMol

Bikinin, a potent inhibitor of plant GSK-3/Shaggy-like kinase, activates BR signaling downstream of the BR receptor.

More Information Supplier Page

CTX-0294885 10 mg  | 99.95%

TargetMol

CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.

More Information Supplier Page

CTX-0294885 50 mg  | 99.95%

TargetMol

CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.

More Information Supplier Page